EMA Cites EU Data Protection Rules, HQ Relocation For 2020 Transparency Dip

Annual Report Shows Fewer Pages and Documents Released For Public Access

30 Jun 2021

Risk management plans submitted to the European Medicines Agency as part of marketing authorization dossiers were the most sought-after document type last year under the agency’s ‘access to documents’ policy.

Macro photo of tooth wheel mechanism with arrows and PRIVATE, PUBLIC letters — EMA redacts personal and commercially confidential data from documents released to public • Source: Shutterstock

In 2020, the European Medicines Agency released a substantially lower number of pages from documents in its possession to which access was requested by EU citizens compared with the figures in the year before.

Specifically, the EMA released 110,995 pages from 1,024 documents last year following “access to documents” requests, compared with 318,013 pages...